Cargando…
The Implication of New Developments in Hemophilia Treatment on Its Laboratory Evaluation
Laboratories monitor hemophilia replacement therapy by specific coagulation factor measurement before and after the infusion of human-derived or recombinant factors. Bypassing agents are now used for patients with inhibitors. Recently, modified long-acting coagulation factors have been introduced, f...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650916/ https://www.ncbi.nlm.nih.gov/pubmed/36381757 http://dx.doi.org/10.7759/cureus.30212 |